About Interleukin GeneticsInterleukin Genetics is a genetics – focused personalized medicine company that preventive consumer protection products and genetic tests for sale develops into a new personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and to develop to test innovative to test innovative preventive and therapeutic products. Interleukin is located in Waltham, MA headquarters. Interleukin Interleukin and its products and ongoing programs, please visit.

Because such statements involve risks and uncertainties, actual results may expressed or implied by expressed or implied by, forward-looking statements. The factors include may cause actual results to differ materially from those expressed or implied may vary in these forward-looking statements include, but are not is limited to, the risk of market acceptance of our products, the risk of technology and product development obsolescence, delays in product development, limited, the performance of our commercial partners, the availability of sufficient capital described the actions of competitors and other competitive risks and the risks and uncertainties in our Annual Report on Form 10-K, in our quarterly reports on Form 10 – Q and other documents we’ll file with or furnish to, the Securities and Exchange Commission.By to the researchers, female tend to be older than men hospitalization for myocardial infarction, said:.

‘It is plausible mortality rate for women higher age at presentation, whether showcase to pain in the chest, as well as subsequent the hospital associated. However, a limited amount of trials are included age in examining sex differences to clinical presentation of MI. ‘.

The investigators a comment: However, did having with chest pains / discomfort, a larger hospital mortality than males having breast pain / discomfort in the the same age group it is appropriate hospital death rate for men and women with age decreased. These data suggest that to absence of breast pain may an important indicator of death in young women with MI as compared with other similar aged groups may be. .